Medical and Health Sciences

You are here

20 Mar 2020
WG

RDA COVID-19

Status: 
Recognised & Endorsed
Secretariat Liaison: 
enquiries@rd-alliance.org
TAB Liaison: 
Isabelle Perseil

 

I.  RDA COVID-19 Working Group Objectives

II.  Group & Website Navigation

III.  Weekly Webinar RDA COVID-19 Updates - Completed

 


I.  RDA COVID-19 Working Group Objectives

The overarching objectives of this Working Group (WG) are:

  1.  To clearly define detailed guidelines on data sharing under the present COVID-19 circumstances to help stakeholders follow best practices to maximize the efficiency of their work,

continue reading

26 Feb 2020
HG

Synthetic (micro)biology, biosafety and biosecurity: policy compliance - ABS Regulation, CBD, The Nagoya & Kuala Lumpur, and Cartagena Protocols

Status: 
Withdrawn
Chair (s): 

 

    TOPICS:

1. Synthetic (micro)biology, biosafety and biosecurity

2. Biotechnology and bioeconomy: sustainable goals, circular economy, "zero pollution"

3. Microbial biotechnology: R&D

4. Microbial resources data management and research infrastructures

5. Public-private biotech sector linkages

6. Financial mechanisms

 

    POLICY:

1. The Convention on Biological Diversity

continue reading

Pages